165 related articles for article (PubMed ID: 9723576)
1. Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil.
Andrade FL; Annichino-Bizzacchi JM; Saad ST; Costa FF; Arruda VR
Am J Hematol; 1998 Sep; 59(1):46-50. PubMed ID: 9723576
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease.
Moreira Neto F; Lourenço DM; Noguti MA; Morelli VM; Gil IC; Beltrão AC; Figueiredo MS
Braz J Med Biol Res; 2006 Oct; 39(10):1291-5. PubMed ID: 16906320
[TBL] [Abstract][Full Text] [Related]
4. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults.
Voetsch B; Damasceno BP; Camargo EC; Massaro A; Bacheschi LA; Scaff M; Annichino-Bizzacchi JM; Arruda VR
Thromb Haemost; 2000 Feb; 83(2):229-33. PubMed ID: 10739378
[TBL] [Abstract][Full Text] [Related]
5. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
[TBL] [Abstract][Full Text] [Related]
6. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.
Fawaz NA; Bashawery L; Al-Sheikh I; Qatari A; Al-Othman SS; Almawi WY
Am J Hematol; 2004 Jul; 76(3):307-9. PubMed ID: 15224376
[TBL] [Abstract][Full Text] [Related]
7. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
[TBL] [Abstract][Full Text] [Related]
8. Effect of the MTHFRC677T variant on risk of venous thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutations.
Brown K; Luddington R; Baglin T
Br J Haematol; 1998 Oct; 103(1):42-4. PubMed ID: 9792287
[TBL] [Abstract][Full Text] [Related]
9. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke.
Lopaciuk S; Bykowska K; Kwiecinski H; Mickielewicz A; Czlonkowska A; Mendel T; Kuczynska-Zardzewialy A; Szelagowska D; Windyga J; Schröder W; Herrmann FH; Jedrzejowska H
Clin Appl Thromb Hemost; 2001 Oct; 7(4):346-50. PubMed ID: 11697722
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients.
Pandey SK; Meena A; Kishor K; Mishra RM; Pandey S; Saxena R
Clin Appl Thromb Hemost; 2012 Jun; 18(3):320-3. PubMed ID: 22084413
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy.
Murphy RP; Donoghue C; Nallen RJ; D'Mello M; Regan C; Whitehead AS; Fitzgerald DJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):266-70. PubMed ID: 10634828
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
Belhaj Nefissi R; Doggui R; Ouali F; Messaoud T; Gritli N
Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836
[TBL] [Abstract][Full Text] [Related]
14. MTHFR polymorphic variant C677T is associated to vascular complications in sickle-cell disease.
Hatzlhofer BL; Bezerra MA; Santos MN; Albuquerque DM; Freitas EM; Costa FF; Araújo AS; Muniz MT
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1038-43. PubMed ID: 22924497
[TBL] [Abstract][Full Text] [Related]
15. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
[TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden (G1691A), the prothrombin 3'-untranslated region variant (G20210A) and thermolabile methylenetetrahydrofolate reductase (C677T): a single genetic test genotypes all three loci--determination of frequencies in the S. Wales population of the UK.
Bowen DJ; Bowley S; John M; Collins PW
Thromb Haemost; 1998 May; 79(5):949-54. PubMed ID: 9609227
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphisms.
Linfert DR; Tsongalis GJ
Diagn Mol Pathol; 2001 Jun; 10(2):111-5. PubMed ID: 11385320
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism, factor V Leiden, and methylenetetrahydrofolate reductase in a sickle cell anemia patient.
Koren A; Zalman L; Levin C; Abu Hana M; Mader R; Shalev S
Pediatr Hematol Oncol; 1999; 16(5):469-72. PubMed ID: 10505325
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss.
Kutteh WH; Park VM; Deitcher SR
Fertil Steril; 1999 Jun; 71(6):1048-53. PubMed ID: 10360908
[TBL] [Abstract][Full Text] [Related]
20. Inherited risk factors for thrombophilia among children with Legg-Calvé-Perthes disease.
Arruda VR; Belangero WD; Ozelo MC; Oliveira GB; Pagnano RG; Volpon JB; Annichino-Bizzacchi JM
J Pediatr Orthop; 1999; 19(1):84-7. PubMed ID: 9890294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
